A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Astellas Pharma Inc
Hoffmann-La Roche
University of California, Irvine
Daiichi Sankyo
I-Mab Biopharma US Limited
Pfizer
Tempus AI
British Columbia Cancer Agency
University of California, Irvine
Elevation Oncology
Novartis
Instituto Nacional de Cancer, Brazil
Hoffmann-La Roche
Jules Bordet Institute
Bayer
Institut de Cancérologie de la Loire
National Institutes of Health Clinical Center (CC)
Amgen
Alliance for Clinical Trials in Oncology
University of Brasilia
Sir Mortimer B. Davis - Jewish General Hospital
GE Healthcare
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center